Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation

Prostate cancer (CaP) in men represents the main cancer cause of years lost due to disabilities in most European countries [1]. Theoretically, focal therapy of CaP enables both cancer control and low treatment related side effects, leading to a reduction of years lost due to disabilities.

https://www.urologiconcology.org/article/S1078-1439(18)30190-X/fulltext?rss=yes

Source: Urologic Oncology: Seminars and Original Investigations - August 6, 2018 Category: Urology & Nephrology Authors: Jost von Hardenberg, Niklas Westhoff, Daniel Baumunk, Daniel Hausmann, Thomas Martini, Alexander Marx, Stefan Porubsky, Martin Schostak, Maurice Stephan Michel, Manuel Ritter Tags: Original article Source Type: research